ZS Whitepapers, Videos and Case Studies

Article

As the U.S. healthcare landscape continues to evolve and as consumers’ media consumption behaviors undergo significant changes, many pharmaceutical brands are continuing to invest in direct-to-consumer advertising—especially TV.

A Stronger Business Starts with Technology and Analytics

Video

A better prepared sales and marketing team, a more informed data scientist, a life sciences organization that is prepared to alter the future of healthcare.

Three Common Challenges When Launching a Marketing Automation Tool and How to Overcome Them

Article

This report presents detailed results from ZS's 2016 Commercial Operations Study for Medtech.

Hidden Dangers Lurking In Your Comp Plan

Infographics

Based on the Explorer Study, this infographic shows that when companies invest in a sales transformation across several prioritized SFE initiatives, they can improve their performance by up to 23% within one year across a number of metrics.

ZS Oncology Value Watchdog Report: Oncology Care Model

Article

This issue of the ZS Oncology Value Watchdog Report summarizes discussions about value that took place at the 2015 ASH conference. It also includes data from the ZS Value and Oncology Practice Management survey of MDs.

Channel Management Technology Landscape

Infographics

This Infographic highlights key insights from the Economist Intelligence Unit study.

Three Hidden Dangers Lurking in Your Sales Comp Plan

Article

This report presents detailed results from ZS's 2016 Commercial Operations Study for Medtech

Is It Time to Flip Your Commercial Model?

Article

Success in today’s IDN-dominant healthcare ecosystem requires that medtech companies shift from being field-sales-centric to key-account centric. Those that succeed will emerge as the winners in an increasingly competitive and complex market. Download this article to learn more.

Video: Why analytics investments have yet to pay off

Video

We believe 2016 will be an exceptional year for some in the channel, but not all.

Medtechs Must Partner With US Providers As Outcomes Revolution Ramps Up

Article

It’s probably a moot point, but history may well show that the element of the US PPACA – the Affordable Care Act of 2010 – that had the most lasting impact was the importance it placed on providers becoming outcomes-focused.

Broken links: Why analytics investments have yet to pay off

Article

This EIU study, "Broken links: Why analytics investments have yet to pay off," sponsored by ZS, draws on survey findings, interviews with senior corporate executives and desk research to explore the current state of sales and marketing analytics.

Helping the Whole Patient: The need to integrate data and understand the entire patient journey

Article

A positive patient outcome is the goal for every Pharma company and information is at the center of this success. This article explores the evolution of patient-related data and what it means for the future of Pharma.

Oncology Value Watchdog Report ASCO 2016: Spotlight on Value

Article

This issue of the ZS Oncology Value Watchdog Report summarizes discussions about value that took place at the 2015 ASH conference. It also includes data from the ZS Value and Oncology Practice Management survey of MDs.